Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

University of Portland's school of engineering named after Bjork-Shiley heart valve inventor

University of Portland's school of engineering will now be known as the Donald P. Shiley School of Engineering in recognition of the late Donald Shiley, a 1951 graduate who was an engineer, inventor, entrepreneur, businessman, philanthropist and loving husband and father. Among his many groundbreaking inventions was the Bjork-Shiley heart valve, an innovative medical device that has been credited with saving more than a half million lives.

4 Dec 2010

Fascinating behaviours of fluids

The new findings will be highly useful to the manufacturing industry because the processing and dispensing of everyday products like toothpaste, cosmetics, pharmaceuticals and foodstuffs depends on an understanding of the physical properties and behaviours of these fluids.

4 Dec 2010

LifeSpan TR1200i folding treadmill named 'Best New Treadmill'

The LifeSpan TR1200i folding treadmill was named "Best New Treadmill" by Treadmill Doctor in their 2011 fitness equipment reviews. Fitness Professor Review also selected the LifeSpan TR1200i, made by PCE Health and Fitness (www.lifespanfitness.com) as its choice for "Best Treadmill under $1000."

3 Dec 2010

Arteriocyte launches Stem Cell Expansion System for research use

Arteriocyte, Inc., a leading clinical stage biotechnology company with offices in Cleveland, Ohio, and Hopkinton, Massachusetts, that develops proprietary stem cell and tissue engineering based therapies announced today the launch of its first commercially available Stem Cell Expansion System for research use.

2 Dec 2010

SAFC Hitech plans new production facility in Taiwan for LED and silicon semiconductor precursors

Following the March 2010 production expansion of trimethylgallium (TMG) at its Bromborough, UK manufacturing site, SAFC Hitech®, a member of the Sigma-Aldrich® Group, reinforced its commitment to the Asia-Pacific electronics markets by announcing plans to build a new, dedicated facility in Kaohsiung, Taiwan for transfilling, technical service and production of LED and silicon semiconductor precursors.

2 Dec 2010

PreCision Dermatology formed as a result of spin-out of Onset Therapeutics

PreCision Dermatology Inc., a company focused on developing, manufacturing, acquiring and marketing a broad portfolio of innovative dermatology products, today announced it was formed as the result of the spin-out of Onset Therapeutics, a wholly-owned subsidiary of Collegium Pharmaceutical, Inc. PreCision Dermatology also announced the close of a Series A financing led by life science private equity investor Essex Woodlands.

2 Dec 2010

CAIRE enters definitive agreement to acquire SeQual

Chart Industries, Inc. announced that its wholly-owned subsidiary, CAIRE Inc., which operates under its BioMedical segment, has entered into a definitive agreement to acquire SeQual Technologies Inc. for approximately $40 million, plus the possibility of up to $20 million of additional future payments contingent on SeQual's financial performance over a two-year period post-closing.

2 Dec 2010

NHS to develop new treatment options for patients with lung disease

Scientists and clinicians in Nottingham are to work more closely with industry to develop new ways of diagnosing and treating lung disease.

2 Dec 2010

Baxter licenses Vero cell-based influenza vaccine technology to Takeda

Baxter International Inc. and Takeda Pharmaceutical Company Limited today announced that the parties have completed a Development, License and Technology Transfer Agreement. Under the terms of the agreement, Takeda and Baxter will expand upon their previously announced collaboration to bring Vero cell culture-based influenza vaccines to the Japanese market.

From Baxter International Inc. 2 Dec 2010

Collegium completes spin-out of Onset Therapeutics

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has completed the spin-out of Onset Therapeutics, LLC, its wholly owned subsidiary focused on the Dermatology market.

2 Dec 2010

CRN issues statement on passage of FDA Food Safety Modernization Act

"CRN is pleased that the Senate today passed S. 510, FDA Food Safety Modernization Act (FDAFSMA). CRN and its member companies support this bill because of the added enforcement tools it would provide to FDA and the extra protections it would provide for consumers.

1 Dec 2010

High levels of variability, inconsistencies found in children's medication labeling and measuring devices

An examination of 200 of the top-selling cough/cold, allergy, analgesic and gastrointestinal over-the-counter liquid medications for children finds that there have been high levels of variability and inconsistencies regarding medication labeling and measuring devices, according to a study that will appear in the December 15 issue of JAMA. The study is being released early online because of its public health importance.

1 Dec 2010

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.

1 Dec 2010

NIA awards Aphios Phase I Fast Track SBIR grant for development of novel AD nanodrug

Aphios® Corporation today announced that it was awarded Phase I of a Fast Track SBIR grant from the National Institute of Aging (NIA), National Institutes of Health (NIH) for Developing a Novel Alzheimer's Disease Nanodrug.

30 Nov 2010

Jiangsu Yanshen found liable for producing and selling inferior quality products

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen"), in which Simcere holds a 52.5% controlling stake, has been found liable for producing and selling inferior quality products by the People's Court of Tianning District, Changzhou City and was sentenced to a fine of RMB4.6 million.

30 Nov 2010

PositiveID to include new bio-sensor application in Wireless Body platform

PositiveID Corporation announced today that it has expanded its Wireless Body platform to include a new bio-sensor application for temperature.

30 Nov 2010

$Bruker’s AcuityXR with ContourGT optical surface profilers break diffraction limit$

Bruker’s AcuityXR with ContourGT optical surface profilers break diffraction limit

Bruker Corporation announced today at the Materials Research Society (MRS) Fall 2010 Meeting the AcuityXR™, a novel optical surface profiler mode that combines unique, patent-pending Bruker hardware and software technology to enable select ContourGT™ non-contact, 3D optical surface profilers to break the optical diffraction limit and deliver lateral resolutions that were previously considered impossible to achieve.

From Bruker Nano Surfaces and Metrology 30 Nov 2010

Dongsheng enters agreement to acquire micro-emulsion alprostadil injection from Wan'Te

Dongsheng Pharmaceutical International Co., Ltd. announced today that it has entered into an agreement with Shanghai Wan'Te Pharmaceutical Co., Ltd. to acquire the intellectual property, exclusive sales and manufacturing rights of micro-emulsion alprostadil injection from Wan'Te for total proceeds of RMB10 million, of which RMB5 million will be paid in cash and RMB5 million will be paid in shares of the Company's common stock.

30 Nov 2010

University of Adelaide researcher leads collaboration for universal flu vaccine

A University of Adelaide researcher is leading a collaboration between Australia and Indonesia on the production of a universal flu vaccine. The frequent arising of new influenza strains represents the greatest challenge to health authorities as it renders currently available vaccines ineffective, says Dr Mohammed Alsharifi, the Head of the Vaccine Research Group at the School of Molecular and Biomedical Science, University of Adelaide.

30 Nov 2010

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).

29 Nov 2010

Manufacturing News and Research

Further Reading

University of Portland's school of engineering named after Bjork-Shiley heart valve inventor

Fascinating behaviours of fluids

LifeSpan TR1200i folding treadmill named 'Best New Treadmill'

Arteriocyte launches Stem Cell Expansion System for research use

SAFC Hitech plans new production facility in Taiwan for LED and silicon semiconductor precursors

PreCision Dermatology formed as a result of spin-out of Onset Therapeutics

CAIRE enters definitive agreement to acquire SeQual

NHS to develop new treatment options for patients with lung disease

Baxter licenses Vero cell-based influenza vaccine technology to Takeda

Collegium completes spin-out of Onset Therapeutics

CRN issues statement on passage of FDA Food Safety Modernization Act

High levels of variability, inconsistencies found in children's medication labeling and measuring devices

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

NIA awards Aphios Phase I Fast Track SBIR grant for development of novel AD nanodrug

Jiangsu Yanshen found liable for producing and selling inferior quality products

PositiveID to include new bio-sensor application in Wireless Body platform

Bruker’s AcuityXR with ContourGT optical surface profilers break diffraction limit

Dongsheng enters agreement to acquire micro-emulsion alprostadil injection from Wan'Te

University of Adelaide researcher leads collaboration for universal flu vaccine

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy